Trial Results

 
News Articles for Trial Results top ^
- Data Presented Today as Late-Breaker at European Society for Medical Oncology (ESMO) 2014 Congress in Madrid - WEST LAFAYETTE, Ind., Sept.
Sign-up for Phase 2b TARGET Trial Results Show Improved Survival in Adenocarcinoma Non-Small Cell Lung Cancer Patients Treated With Endocyte's Vintafolide investment picks
The Medicines Company (NASDAQ: MDCO) today announced the presentation of the results of the pivotal Phase III clinical trial of the investigational hemostatic agent RAPLIXA™ (fibrin sealant), formerly known as Fibrocaps, at the 100 th Clinical Congress of the American College of Surgeons in San Francisco, CA.
Sign-up for The Medicines Company Announces Presentation of Investigational Hemostatic Agent RAPLIXA™ (fibrin sealant) Phase III FINISH-3 Trial Results at the 2014 Clinical Conference of the American College of Surgeons investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting investment picks
HASBROUCK HEIGHTS, N.J., Sept.
Sign-up for Nymox Announces Positive Prostate Cancer 8 Month Clinical Trial Results investment picks
RESEARCH TRIANGLE PARK, N.C., Oct.
Sign-up for RAPIVAB(TM) Trial Results for the Treatment of Influenza to be Presented at IDWeek 2014 investment picks
RESEARCH TRIANGLE PARK, N.C., Oct.
Sign-up for BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress investment picks
CASTLE ROCK, Colo.
Sign-up for Venaxis Announces APPY1 Test Clinical Trial Results to be Presented at ACEP14 investment picks
Results indicate Zalviso controlled moderate-to-severe acute pain following abdominal surgery better than placebo, with similar side effect profile REDWOOD CITY, Calif.
Sign-up for AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results investment picks
CASTLE ROCK, Colo.
Sign-up for Venaxis' APPY1 Trial Results Presented by Dr. David S. Huckins, M.D., at ACEP14 investment picks
SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for Sunesis Announces Publication of REVEAL-1 Trial Results in the British Journal of Haematology investment picks
SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for Sunesis Announces Publication of Vosaroxin Phase 1b/2 AML Trial Results in Haematologica investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Trial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Trial Research  |  Next: Trimming Losses